Year: 1998
Type: article
Abstract: XPANDED PARTICIPATION of women in clinical trials is important to developing therapies that better promote the health of women.In 1993, the Food and Drug Administration revised its policy to emphasize the crucial need for developing drug studies that examine gender differences in pharmacokinetics (Cotton, 1993).Increasing the number of women recruited and retained in clinical trials is critical to understand the impact and interaction of gender on behavior, health, and therapeutic interventions (Allen, 1994;Levine, 1994;
Source: Applied Nursing Research
Authors: Kathleen M. Neill, Frank Chessa
Institution: Georgetown University
Language: English
Topic: Ethics in Clinical Research
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,690
OpenAlex ID: W2018261286
